Protagenic Therapeutics financial statements provide useful quarterly and yearly information to potential Protagenic Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Protagenic Therapeutics financial statements helps investors assess Protagenic Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Protagenic Therapeutics' valuation are summarized below:
Market Capitalization
4 M
Earnings Share
(1.27)
We have found one hundred twenty available trending fundamental ratios for Protagenic Therapeutics, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Protagenic Therapeutics recent market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 4.7 M in 2025. Enterprise Value is likely to drop to about 3.3 M in 2025
About Protagenic Therapeutics Financial Statements
Protagenic Therapeutics investors use historical fundamental indicators, such as Protagenic Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Protagenic Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.